Sage is a biopharmaceutical company focused on developing novel therapies for people with debilitating brain disorders. For a clinical trial, they needed to recruit patients suffering from super-refractory status epilepticus (SRSE), a life-threatening, persistent neurological state of seizure that doesn’t respond to first-, second- or third-line treatments. Because patients who qualify would be in a medically induced coma, we had to educate both physicians and families by creating two videos — one focused on awareness of the condition and the other, on the clinical trial.